View/Open - Scholarly Commons Home
View/Open - Scholarly Commons Home
View/Open - Scholarly Commons Home
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
could also be reported as a nested case-control study with an historical comparison<br />
group.<br />
Advantages of case-control studies are described as being able to study rare<br />
diseases with a relatively small sample size and are generally less expensive. The two<br />
most commonly cited disadvantages of case-controlled studies however are described as<br />
confounding and bias, that is, the difficulty in describing cause and effect ( confounding<br />
variables) and bias, in particular recall bias with cases over reporting and cases under<br />
reporting an exposure (Bombardier, Kerr, Shannon, & Frank, 1994). The case-<br />
controlled design is appropriate for this study as childhood cancer is an uncommon<br />
disease and it would have been difficult to recruit a large sample. Data had already been<br />
collected from a normative control group that was current and provided a large<br />
representative sample of the same source population i.e. New Zealand youth aged<br />
between 12- 18 years. This large control group allowed for multivariate comparison<br />
with child cancer survivors with allowance for differences between the groups, in age,<br />
sex, ethnicity and socioeconomic status to control for those potentially confounding<br />
variables.<br />
3.4 Cases: Childhood Cancer Survivors<br />
There are two primary cancer treatment centres (Auckland and Christchurch)<br />
supported by a network of regional outreach services throughout New Zealand. These<br />
provide supportive and follow-up care to patients domiciled outside the main treatment<br />
centres. These links made it easier to identify and obtain current contact details for<br />
prospective participants.<br />
Inclusion criteria were all survivors of a childhood disease that met the<br />
International Classification of Childhood Cancers version 3 (ICCD-3), aged between 12<br />
years and 18 years inclusive at the commencement of the study and who were at least<br />
two years from completion of therapy and disease free. Participants had to have English<br />
19